LINC02740: A Potential Drug Target and Biomarker (G100507205)

Target Name: LINC02740

NCBI ID: G100507205

LINC02740

Other Name(s): long intergenic non-protein coding RNA 2740 | Long intergenic non-protein coding RNA 2740

LINC02740: A Potential Drug Target and Biomarker

LINC02740 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and has been shown to play a role in a variety of cellular processes, including cell growth, apoptosis, and tissue development. LINC02740 is also known as NS1 and has been shown to interact with several protein kinases, including S6 and S4.

The drug target potential of LINC02740 is due to its unique structure and the various functions it has been shown to have. LINC02740 is a small non-coding RNA molecule that is highly conserved across different species. It has a characteristic stem-loop structure and is composed of three exons. The first exon codes for the amino acid Asp, which is a key residue that is involved in protein-protein interactions. The second exon codes for the amino acid Asn, which is a non-coding RNA molecule. The third exon codes for the amino acid Asp, which is a key residue that is involved in protein-protein interactions.

The functions of LINC02740 have been shown to be involved in the regulation of the cell cycle, specifically in the G1 phase. G1 phase is a critical phase of the cell cycle where the cell prepares for cell division. LINC02740 has been shown to regulate the length of the G1 phase and the length of the S-phase, which is the phase of the cell cycle where the cell prepares for cell division.

In addition to its role in regulating the cell cycle, LINC02740 has also been shown to play a role in apoptosis. Apoptosis is a natural process that is involved in the regulation of cell life-span. It is a process that is characterized by the programmed death of cells, which is necessary for the development and maintenance of a healthy tissue. LINC02740 has been shown to play a role in the regulation of apoptosis, specifically in the regulation of the execution of apoptotic cells.

The potential drug target of LINC02740 is due to its interaction with several protein kinases, including S6 and S4. S6 and S4 are two of the most well-known protein kinases that are involved in the regulation of the cell cycle. S6 is a protein kinase that is involved in the regulation of the centrosome, which is a structure that is responsible for the proper positioning of chromosomes during the cell cycle. S4 is a protein kinase that is involved in the regulation of the G1 phase and the G2 phase of the cell cycle.

In conclusion, LINC02740 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and the various functions it has been shown to have, including regulating the cell cycle and playing a role in apoptosis, make it an attractive target for drug development. Further research is needed to fully understand the mechanisms of LINC02740 and its potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 2740

The "LINC02740 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02740 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets